HaemoCer™ PLUS Absorbable Polysaccharide Haemostat (APH) is a proprietary patent pending technology based on BioCers Polysacharide Ultra-hydrophilic Resorbable Engineering (PURE) process.
HaemoCer™ PLUS APH incorporates a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. Once in contact with blood, HaemoCer™ PLUS enhances the natural clotting cascade by rapidly dehydrating the blood and accelerating the concentration of platelets, red blood cells and coagulation proteins at the bleeding site. The second mode of action of HaemoCer™ PLUS is the formation of a robust gelled matrix that adheres to the bleeding site and forms a mechanical barrier to prevent further bleeding.
HaemoCer™ PLUS is rapidly resorbed by amylase within a few days without leaving any residues behind, depending on the amount of used material and the place of application.
Latest studies demonstrate that HaemoCer™ PLUS reduces postoperative adhesions.